Is Lumbopelvic Pain in Pregnancy Under-Reported?

-A new study has shown that pregnancy-related lumbopelvic pain is under-reported to healthcare providers (HCPs), and under-treated, even though treatment is usually effective. The study, which found that difficulty with daily mobility and a later stage of pregnancy increased the likelihood of patients informing their HCPs, is published in the peer-reviewed Journal of Women's Health. Click here to read the article now.

Farah Hameed, MD, from Columbia University Irving Medical Center, and coauthors, reported that only 43% of 538 pregnant women who had lower back and pelvic girdle pain reported the pain to their HCP. Of those who reported lumbopelvic pain, 22% received treatment, of which 80% said that treatment was effective.

"Healthcare providers treating pregnant patients should ask about lumbopelvic pain, and if the pain is disruptive to activities of daily living, sleep, or quality of life, should offer treatment," says Journal of Women's Health Editor-in-Chief Susan G. Kornstein, MD, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA.

About the Journal

Journal of Women's Health, published monthly, is a core multidisciplinary journal dedicated to the diseases and conditions that hold greater risk for or are more prevalent among women, as well as diseases that present differently in women. Led by Editor-in-Chief Susan G. Kornstein, MD, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA, the Journal covers the latest advances and clinical applications of new diagnostic procedures and therapeutic protocols for the prevention and management of women's healthcare issues. Complete tables of content and a sample issue may be viewed on the Journal of Women's Health website. Journal of Women's Health is the official journal of the Society for Women's Health Research.

About the Publisher

Mary Ann Liebert, Inc., publishers is a global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services to advance the fields of biotechnology and the life sciences, specialized clinical medicine, and public health and policy. For complete information, please visit the Mary Ann Liebert, Inc., publishers website.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.